Conventional vs. Lipid-based product confusion and nurse dilution of drugs

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

1 post / 0 new
Rich S Darryl
Rich S Darryl's picture
Offline
Last seen: 6 years 6 months ago
Joined: 04/30/2014 - 15:12
Conventional vs. Lipid-based product confusion and nurse dilution of drugs

I was wondering if anyone have develop effective strategies for:

  1. Preventing confusion between conventional and lipid-based (liposomal) products of the same drug product. I know some people have dealt with amphotericin B vs. liposomal amphotericin B by only stocking one agent, but am curious about what people have done when both products are needed (like chemo).
  2. Getting nurses to NOT dilute drugs on the patient care unit that do not require dilution?

If you feel that you have a good process for either of these two issues, I would appreciate if you would respond in this forum or send me a separate email at drich@ismp.org. I would like to talk with you about what you have done.